Injection device
Latest ARES TRADING S.A. Patents:
- Anti-retroviral treatment using growth hormone
- COMBINED INHIBITION OF PD-1, TGFBeta AND ATM TOGETHER WITH RADIOTHERAPY FOR THE TREATMENT OF CANCER
- IGG:TGFBETARII FUSION PROTEIN COMPOSITION
- Methods for modulating protein mannosylation profiles using maduramycin, narasin, or salinomycin
- Tip determiner for an injection device
Description
The portions of the design shown in broken lines show unclaimed subject matter.
Claims
The ornamental design for an injection device, as shown and described.
Referenced Cited
U.S. Patent Documents
D535031 | January 9, 2007 | Barrett et al. |
D545438 | June 26, 2007 | Huang et al. |
D550364 | September 4, 2007 | Glover et al. |
D562985 | February 26, 2008 | Brefka et al. |
D606659 | December 22, 2009 | Kiani et al. |
D621515 | August 10, 2010 | Chua et al. |
D622393 | August 24, 2010 | Gatrall et al. |
D634435 | March 15, 2011 | Chua et al. |
D647621 | October 25, 2011 | Lee et al. |
D662923 | July 3, 2012 | Piedra et al. |
D695391 | December 10, 2013 | Takemoto et al. |
D695394 | December 10, 2013 | Takemoto et al. |
20090216182 | August 27, 2009 | Lauchard et al. |
Patent History
Patent number: D741995
Type: Grant
Filed: Sep 17, 2013
Date of Patent: Oct 27, 2015
Assignee: ARES TRADING S.A. (Aubonne)
Inventors: Robert Prasser (Guttaring), Werner Wurmbauer (Klagenfurt)
Primary Examiner: David Muller
Assistant Examiner: Nathan Johnston
Application Number: 29/467,238
Type: Grant
Filed: Sep 17, 2013
Date of Patent: Oct 27, 2015
Assignee: ARES TRADING S.A. (Aubonne)
Inventors: Robert Prasser (Guttaring), Werner Wurmbauer (Klagenfurt)
Primary Examiner: David Muller
Assistant Examiner: Nathan Johnston
Application Number: 29/467,238
Classifications
Current U.S. Class:
Hand Actuated Flow Control (e.g., Lever, Button, Etc.) (D24/113)